News

This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use," FDA Commissioner Martin A.
The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, Bristol Myers Squibb) for the treatment of adults and children aged 12 ...
A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...
The United States Food and Drug Administration (FDA) is recalling bottles of hot sauce due to mislabeling. On April 3, T.W. Garner Food Company announced a recall of its Texas Pete Habanero ...
FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1 ...
The justices threw out a lower court's decision that the FDA had failed to follow proper legal procedures under a federal law called the Administrative Procedure Act when it rejected the ...
Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, resigns after being pressured by HHS Secretary RFK Jr. Marks criticized Kennedy for promoting vaccine ...
The FDA recalled over 4,000 bags of ground coffee mislabeled as decaffeinated across 15 states. The recall applies to 12-ounce bags of Our Family's Traverse City Cherry Decaf Light Roast.
Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to public health. By Christina Jewett Sheryl Gay Stolberg and Noah Weiland The ...
Dr. Peter Marks sent a letter to Acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.
Dr. Peter Marks sent a letter to acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.
Greg Nash/The Hill/Bloomberg via Getty; Kevin Dietsch/Getty Dr. Peter Marks, one of the U.S. Food and Drug Administration’s (FDA) top vaccine officials, has resigned. In a resignation letter ...